Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
Abstract Background: Melatonin (MLT) can improve mitophagy, thereby ameliorating cognitive deficits in Alzheimer’s disease (AD) patients. Hence, our research focused on the potential value of MLT-related genes (MRGs) in AD through bioinformatic analysis. Methods: First, the key cells in the single-c...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-80755-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823862530190082048 |
---|---|
author | Hua-xiong Zhang Dilmurat Hamit Qing Li Xiao Hu San-feng Li Fu Xu Ming-yuan Wang Guo-qing Bao Hong-yan Li |
author_facet | Hua-xiong Zhang Dilmurat Hamit Qing Li Xiao Hu San-feng Li Fu Xu Ming-yuan Wang Guo-qing Bao Hong-yan Li |
author_sort | Hua-xiong Zhang |
collection | DOAJ |
description | Abstract Background: Melatonin (MLT) can improve mitophagy, thereby ameliorating cognitive deficits in Alzheimer’s disease (AD) patients. Hence, our research focused on the potential value of MLT-related genes (MRGs) in AD through bioinformatic analysis. Methods: First, the key cells in the single-cell dataset GSE138852 were screened out based on the proportion of annotated cells and Fisher’s test between the AD and control groups. The differentially expressed genes (DEGs) in the key cell and GSE5281 datasets were identified, and the MRGs in GSE5281 were selected via weighted gene coexpression network analysis. After intersecting two sets of DEGs and MRGs, we performed Mendelian randomization analysis to identify the MRGs causally related to AD. Biomarkers were further ascertained through receiver operating characteristic curve (ROC) and expression analysis in GSE5281 and GSE48350. Furthermore, gene set enrichment analysis, immune infiltration analysis and correlation analysis with metabolic pathways were conducted, as well as construction of a regulator network and molecular docking. Results: According to the Fisher test, oligodendrocytes were regarded as key cells due to their excellent abundance in the GSE138852 dataset, in which there were 281 DEGs between the AD and control groups. After overlapping with 3,490 DEGs and 550 MRGs in GSE5281, four genes were found to be causally related to AD, namely, G protein-coupled receptor, family C, group 5, member B (GPRC5B), Methyltransferase-like protein 7 A (METTL7A), NF-κB inhibitor alpha (NFKBIA) and RAS association domain family 4(RASSF4). Moreover, GPRC5B, NFKBIA and RASSF4 were deemed biomarkers, except for METTL7A, because of their indistinctive expression between the AD and control groups. Biomarkers might be involved in oxidative phosphorylation, adipogenesis and heme metabolism. Moreover, T helper type 17 cells, natural killer cells and CD56dim natural killer cells were significantly correlated with biomarkers. Transcription factors (GATA2, POU2F2, NFKB1, etc.) can regulate the expression of biomarkers. Finally, we discovered that all biomarkers could bind to MLT with a strong binding energy. Conclusion: Our study identified three novel biomarkers related to MLT for AD, namely, GPRC5B, NFKBIA and RASSF4, providing a novel approach for the investigation and treatment of AD patients. |
format | Article |
id | doaj-art-f0d375ddb01e4d21bf9f6413a8cc86c5 |
institution | Kabale University |
issn | 2045-2322 |
language | English |
publishDate | 2025-02-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj-art-f0d375ddb01e4d21bf9f6413a8cc86c52025-02-09T12:31:05ZengNature PortfolioScientific Reports2045-23222025-02-0115111810.1038/s41598-024-80755-xIntegrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s diseaseHua-xiong Zhang0Dilmurat Hamit1Qing Li2Xiao Hu3San-feng Li4Fu Xu5Ming-yuan Wang6Guo-qing Bao7Hong-yan Li8Department of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Neurology, People’s Hospital of Xinjiang Uygur Autonomous RegionAbstract Background: Melatonin (MLT) can improve mitophagy, thereby ameliorating cognitive deficits in Alzheimer’s disease (AD) patients. Hence, our research focused on the potential value of MLT-related genes (MRGs) in AD through bioinformatic analysis. Methods: First, the key cells in the single-cell dataset GSE138852 were screened out based on the proportion of annotated cells and Fisher’s test between the AD and control groups. The differentially expressed genes (DEGs) in the key cell and GSE5281 datasets were identified, and the MRGs in GSE5281 were selected via weighted gene coexpression network analysis. After intersecting two sets of DEGs and MRGs, we performed Mendelian randomization analysis to identify the MRGs causally related to AD. Biomarkers were further ascertained through receiver operating characteristic curve (ROC) and expression analysis in GSE5281 and GSE48350. Furthermore, gene set enrichment analysis, immune infiltration analysis and correlation analysis with metabolic pathways were conducted, as well as construction of a regulator network and molecular docking. Results: According to the Fisher test, oligodendrocytes were regarded as key cells due to their excellent abundance in the GSE138852 dataset, in which there were 281 DEGs between the AD and control groups. After overlapping with 3,490 DEGs and 550 MRGs in GSE5281, four genes were found to be causally related to AD, namely, G protein-coupled receptor, family C, group 5, member B (GPRC5B), Methyltransferase-like protein 7 A (METTL7A), NF-κB inhibitor alpha (NFKBIA) and RAS association domain family 4(RASSF4). Moreover, GPRC5B, NFKBIA and RASSF4 were deemed biomarkers, except for METTL7A, because of their indistinctive expression between the AD and control groups. Biomarkers might be involved in oxidative phosphorylation, adipogenesis and heme metabolism. Moreover, T helper type 17 cells, natural killer cells and CD56dim natural killer cells were significantly correlated with biomarkers. Transcription factors (GATA2, POU2F2, NFKB1, etc.) can regulate the expression of biomarkers. Finally, we discovered that all biomarkers could bind to MLT with a strong binding energy. Conclusion: Our study identified three novel biomarkers related to MLT for AD, namely, GPRC5B, NFKBIA and RASSF4, providing a novel approach for the investigation and treatment of AD patients.https://doi.org/10.1038/s41598-024-80755-xAlzheimer’s diseaseMLTMendelian randomizationBiomarkerMolecular docking |
spellingShingle | Hua-xiong Zhang Dilmurat Hamit Qing Li Xiao Hu San-feng Li Fu Xu Ming-yuan Wang Guo-qing Bao Hong-yan Li Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease Scientific Reports Alzheimer’s disease MLT Mendelian randomization Biomarker Molecular docking |
title | Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease |
title_full | Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease |
title_fullStr | Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease |
title_full_unstemmed | Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease |
title_short | Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease |
title_sort | integrative bioinformatic approach reveals novel melatonin related biomarkers for alzheimer s disease |
topic | Alzheimer’s disease MLT Mendelian randomization Biomarker Molecular docking |
url | https://doi.org/10.1038/s41598-024-80755-x |
work_keys_str_mv | AT huaxiongzhang integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease AT dilmurathamit integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease AT qingli integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease AT xiaohu integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease AT sanfengli integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease AT fuxu integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease AT mingyuanwang integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease AT guoqingbao integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease AT hongyanli integrativebioinformaticapproachrevealsnovelmelatoninrelatedbiomarkersforalzheimersdisease |